September 18, 2017

At the request of the Joint Task Force on Practice Parameters, you are invited to review the DRAFT Administration of Influenza Vaccines to Egg-Allergic Recipients: A Practice Parameter Update - 2017. The Joint Task Force will be taking comments until October 2, 2017. To provide your suggested revisions and/or comments, using a Word document, please list the page and line number before your revision/recommendation and forward to Natalie Aumann at NAumann@aaaai.org. Please take advantage of this opportunity to assist your colleagues in shaping the specialty. CLICK HERE FOR DRAFT.

September 7, 2017

The U.S. Food and Drug Administration (FDA) has announced a major change in food labeling regarding peanut allergy in infants. The claim, which manufacturers can use immediately, reads:

“For most infants with severe eczema and/or egg allergy who are already eating solid foods, introducing foods containing ground peanuts between 4 and 10 months of age and continuing consumption may reduce the risk of developing peanut allergy by 5 years of age. FDA has determined, however, that the evidence supporting this claim is limited to one study.